Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid in infants with severe osteogenesis imperfecta
NCT00982124Phase 3Completed
- Sponsor
- Shriners Children's
- Start
- Oct 2007
- Primary completion
- Sep 2015
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in osteogenesis imperfecta (OI), sponsored by Shriners Children's. Started Oct 2007; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteogenesis imperfecta (OI)
Beyond the preview
Go deeper on NCT00982124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00982124.